Back to Trials
NCT06564571Recruiting

Artificial Intelligence in Endoscopic Ultrasound

Orlando Health, Inc.

Start Date

1/19/2024

Completion Date

12/1/2027

Summary

The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.

Detailed Description

Endoscopic Ultrasound (EUS) is an equipment where an ultrasound transducer is attached to the tip of the endoscope. When advanced to the stomach the organs outside such as the pancreas and liver can be visualized in great detail. This enables diagnosis of conditions such as pancreatic cancer. However, an endoscopist must undergo training to accurately interpret these ultrasound images. The investigators are in the process of developing an artificial intelligence system that could potentially interpret EUS images. The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures. Such correlation if established will lead to possible development of an artificial intelligence platform that can diagnose pancreatic diseases. Such development will potentially minimize human error and decrease learning curve to gain proficiency in EUS.

Eligibility Criteria

Age Range: 18 years to 100 years

Inclusion Criteria: * Age ≥ 18 years * Any patient undergoing endoscopic ultrasound examination Exclusion Criteria: * Age \< 18 years

Interventions

DEVICE

Patients undergoing endoscopic ultrasound procedures

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Pancreatic CancerPancreas DiseasePancreatic Cyst

Locations

Orlando Health

Orlando, Florida 32806

United States